Skip to search formSkip to main contentSkip to account menu

Oxprenolol:MCnc:Pt:Ser/Plas:Qn

Known as: ??????:????:????:??/??:??, oxprenolol:concentración de masa:punto en el tiempo:plasma:cuantitativo:, Oxprenolol:Mass Concentration:Point in time:Serum/Plasma:Quantitative 
National Institutes of Health

Related topics

Related topics

9 relations
OxprenololOxprenolol HydrochloridePlasPlasma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Twenty-four hour effects of oxprenolol oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion
SummaryThe effects of oxprenolol, a non-selective beta-blocker with moderate intrinsic sympathomimetic activity (ISA), given by… 
1995
1995
Stereoselective pharmacokinetics of oxprenolol and its glucuronides in humans
1992
1992
Hydrophobic Anionic Gel Beads for Swelling-Controlled Drug Delivery
Using oxprenolol HC1 as a model drug, the effects of pH and buffer concentration on the swelling and drug release properties in… 
1988
1988
Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol Oros 16/260 drug delivery system within the gastrointestinal tract as…
1. The position in the gastrointestinal tract of an orally administered oxprenolol Oros drug delivery system labelled with… 
1985
1985
Simultaneous determination of oxprenolol and 2H6-labelled oxprenolol in human plasma by gas chromatography/mass spectrometry.
A gas chromatographic/mass spectrometric method for the specific determination of oxprenolol and 2H6-labelled oxprenolol when… 
1985
1985
Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily.
Nineteen patients receiving oxprenolol slow-release (SR) 160 mg (three patients) or 320 mg (16 patients) once daily for mild to… 
1982
1982
Thrombocytopenia secondary to oxprenolol, a beta-blocking agent.
Giovanni M. Patrassi, Alessandra Casonato, Fabrizio Fabris, Antonio Girolami, Institute of Semeiotica Medica, University of Padua… 
1981
1981
高血圧における OXPRENOLOL の血漿レニン活性ならびに尿中カテコールアミンに及ぼす効果 : 第65回日本循環器学会東北地方会
1979
1979
Blutdruck und Nierenfunktion unter einer Oxprenolol-Chlorthalidon-Hydralazin-Kombinationstherapie
Kombinationen von Betablockern, Diuretika und Vasodilatatoren werden aufgrund einer gunstigen Wirkungs- zu Nebenwirkungsrelation… 
1974
1974
Treatment of Moderately Severe Essential Hypertension in General Practice with a Combination of Cyclopenthiazide with Potassium Chloride (Navidrex K) and Oxprenolol (Trasicor 80mg): A Report on 554…
Five hundred and fifty-four patients, with an initial mean diastolic pressure of 130 mm Hg, were treated with a combination of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)